Publication | Open Access
EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES
28
Citations
0
References
2024
Year
Chronic Inflammatory DiseasesImmunologyGastroenterologyClinical GastroenterologyThe Galaxi 2Ulcerative ColitisMedicinePhase 3
No additional data available for this publication yet. Check back later!